CIK 1515070
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Software | 60.80% | 4 |
| Pharmaceuticals & Biotechnology | 22.33% | 25 |
| Oil, Gas & Consumable Fuels | 7.37% | 1 |
| Media & Entertainment | 4.98% | 1 |
| Commercial Services & Supplies | 2.61% | 1 |
| Unclassified | 1.90% | 2 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | PATH | UiPath, Inc. | Information Technology | 54.98% |
| 2 | KGEI | Kolibri Global Energy Inc. | Energy | 7.37% |
| 3 | WBD | Warner Bros. Discovery, Inc. | Communication Services | 4.98% |
| 4 | WK | WORKIVA INC | Information Technology | 2.93% |
| 5 | LYFT | Lyft, Inc. | Industrials | 2.61% |
| 6 | CXM | Sprinklr, Inc. | Information Technology | 2.59% |
| 7 | AUTL | Autolus Therapeutics plc | Health Care | 2.58% |
| 8 | CLDX | Celldex Therapeutics, Inc. | Health Care | 1.95% |
| 9 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Health Care | 1.57% |
| 10 | NKTR | NEKTAR THERAPEUTICS | Health Care | 1.46% |
32/34 names classified · sector 98.1% of weight · industry 98.1% · mkt cap 98.1%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 98.1% of the book is sector-classified (unclassified names shown, never dropped).
Classified: 67.6% of book weight (7/34 names) · unclassified 32.4%: KGEI, WK, AUTL, CLDX, ARWR, NKTR, ANNX, PHVS, AGIO, IMVT +17 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | PATHUIPATH INC | 25,207,628 | $280M | 55.0% | ADD 44% |
| 2 | KGEIKOLIBRI GLOBAL ENERGY INC | 6,834,504 | $38M | 7.4% | HOLD |
| 3 | WBDWARNER BROS DISCOVERY INC | 923,725 | $25M | 5.0% | NEW |
| 4 | WKWORKIVA INC | 250,000 | $15M | 2.9% | ADD 67% |
| 5 | LYFTLYFT INC | 1,000,000 | $13M | 2.6% | HOLD |
| 6 | CXMSPRINKLR INC | 2,200,000 | $13M | 2.6% | HOLD |
| 7 | AUTLAUTOLUS THERAPEUTICS PLC | 9,500,000 | $13M | 2.6% | HOLD |
| 8 | CLDXCELLDEX THERAPEUTICS INC NEW | 312,316 | $10M | 1.9% | ADD 28% |
| 9 | ARWRARROWHEAD PHARMACEUTICALS IN | 127,198 | $8M | 1.6% | ADD 31% |
| 10 | NKTRNEKTAR THERAPEUTICS | 103,037 | $7M | 1.5% | ADD 49% |
| 11 | ANNXANNEXON INC | 1,292,455 | $7M | 1.4% | TRIM −36% |
| 12 | PHVSPHARVARIS N V | 221,611 | $6M | 1.2% | ADD 14% |
| 13 | ALKSALKERMES PLC | 159,791 | $6M | 1.1% | ADD 13% |
| 14 | AGIOAGIOS PHARMACEUTICALS INC | 164,839 | $6M | 1.1% | HOLD |
| 15 | IMVTIMMUNOVANT INC | 218,507 | $5M | 1.1% | ADD 31% |
| 16 | PRAXPRAXIS PRECISION MEDICINES I | 15,952 | $5M | 1.0% | TRIM −30% |
| 17 | KRYSKRYSTAL BIOTECH INC | 19,668 | $5M | 1.0% | ADD 66% |
| 18 | DYNDYNE THERAPEUTICS INC | 258,132 | $5M | 0.9% | ADD 4% |
| 19 | AMLXAMYLYX PHARMACEUTICALS INC | 317,877 | $4M | 0.9% | ADD 17% |
| 20 | MBXMBX BIOSCIENCES INC | 145,480 | $4M | 0.9% | HOLD |
| 21 | DFTXDEFINIUM THERAPEUTICS INC COM SHS | 199,994 | $4M | 0.7% | NEW |
| 22 | SOLENO THERAPEUTICS INC | 102,125 | $3M | 0.7% | NEW |
| 23 | AXSMAXSOME THERAPEUTICS INC. | 20,059 | $3M | 0.7% | TRIM −26% |
| 24 | HRMYHARMONY BIOSCIENCES HLDGS IN | 119,340 | $3M | 0.7% | ADD 44% |
| 25 | SLNSILENCE THERAPEUTICS PLC | 630,161 | $3M | 0.7% | ADD 72% |
| 26 | ACADACADIA PHARM | 144,620 | $3M | 0.6% | NEW |
| 27 | IONSIONIS PHARMACEUTICALS INC | 41,764 | $3M | 0.6% | NEW |
| 28 | MPLTMAPLIGHT THERAPEUTICS INC | 112,115 | $2M | 0.4% | TRIM −32% |
| 29 | RLAYRELAY THERAPEUTICS INC | 181,543 | $2M | 0.4% | NEW |
| 30 | SNOWSNOWFLAKE INC | 10,000 | $2M | 0.3% | HOLD |
| 31 | AARDAARDVARK THERAPEUTICS INC | 316,621 | $1M | 0.2% | NEW |
| 32 | TECXTECTONIC THERAPEUTIC INC | 37,588 | $1M | 0.2% | NEW |
| 33 | RAREULTRAGENYX PHARMACEUTICAL IN | 39,473 | $826,959 | 0.2% | NEW |
| 34 | KPTIKARYOPHARM THERAPEUTICS INC | 52,984 | $295,121 | 0.1% | NEW |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| PATHUIPATH INC | 7.0M | 8.9M | 13.7M | 16.9M | 17.4M | 25.2M | $280M |
| KGEIKOLIBRI GLOBAL ENERGY INC | 7.1M | 7.1M | 7.1M | 7.1M | 6.9M | 6.8M | $38M |
| WBDWARNER BROS DISCOVERY INC | — | — | — | — | — | 924K | $25M |
| WKWORKIVA INC | — | — | 150K | 150K | 150K | 250K | $15M |
| LYFTLYFT INC | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | $13M |
| CXMSPRINKLR INC | 2.2M | 2.2M | 2.2M | 2.2M | 2.2M | 2.2M | $13M |
| AUTLAUTOLUS THERAPEUTICS PLC | 8.3M | 8.6M | 9.5M | 9.5M | 9.5M | 9.5M | $13M |
| CLDXCELLDEX THERAPEUTICS INC NEW | 192K | 261K | 316K | 304K | 244K | 312K | $10M |
| ARWRARROWHEAD PHARMACEUTICALS IN | — | — | — | 82K | 97K | 127K | $8M |
| NKTRNEKTAR THERAPEUTICS | — | — | — | — | 69K | 103K | $7M |
| ANNXANNEXON INC | 1.4M | 2.6M | 2.8M | 2.1M | 2.0M | 1.3M | $7M |
| PHVSPHARVARIS N V | — | 127K | 188K | 195K | 195K | 222K | $6M |
| ALKSALKERMES PLC | — | — | 16K | 90K | 141K | 160K | $6M |
| AGIOAGIOS PHARMACEUTICALS INC | — | — | — | — | 162K | 165K | $6M |
| IMVTIMMUNOVANT INC | — | 131K | 148K | 188K | 166K | 219K | $5M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
